Press releaseBusiness Wire
TG Therapeutics
TGTX · NASDAQ
$54.53+$1.23 (+2.31%)TodayMarket closed ·
Prev close $53.30
Latest news
- Press releaseBusiness Wire
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026
- Press releasePRNewswire
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm
- NewsChandrima Sanyal
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
- Press releaseGlobe Newswire
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
- Press releaseGlobe Newswire
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Press releaseGlobe Newswire
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
- Press releaseBusiness Wire
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
- News
TG Therapeutics Q2 EPS $0.05 Misses $0.33 Estimate, Sales $240.335M Beat $229.721M Estimate
- Press releaseGlobe Newswire
TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance
- Press releaseGlobe Newswire
TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update
- Press releasePRNewswire
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm
- Press releaseGlobe Newswire
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
- Press releaseGlobe Newswire
The Quest to Repair What Multiple Sclerosis Takes Away
- NewsHenry Khederian
TG Therapeutics Stock Rises Thursday: What's Driving The Gains?
- NewsHenry Khederian
TG Therapeutics Stock Is Surging Today: What's Driving The Action?
- NewsAvi Kapoor
Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Other Big Stocks Moving Higher On Wednesday
- NewsVandana Singh
Why Is TG Therapeutics Stock Gaining Tuesday?
- Press releaseGlobe Newswire
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
- NewsHenry Khederian
TG Therapeutics Stock Surges After Drug Trial Update
- News
Earnings Scheduled For May 6, 2026
- News
TG Therapeutics Q1 Adj. EPS $0.18 Misses $0.30 Estimate, Sales $204.918M Beat $196.814M Estimate
- Press releaseBusiness Wire
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update
- Press releaseBusiness Wire
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update
- Press releaseBusiness Wire
Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis
- News
TG Therapeutics Q4 Earnings Assessment
- News
Earnings Scheduled For February 26, 2026
- News
A Look at TG Therapeutics's Upcoming Earnings Report
- News
10 Health Care Stocks With Whale Alerts In Today's Session
- NewsRishabh Mishra
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)
- News
Market-Moving News for January 14th
- News
10 Health Care Stocks Whale Activity In Today's Session
- News
10 Health Care Stocks Whale Activity In Today's Session
- NewsErica Kollmann
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
- News
Earnings Preview For TG Therapeutics
- NewsVandana Singh
Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity
- News
10 Health Care Stocks Whale Activity In Today's Session
- NewsAvi Kapoor
Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results
- NewsVandana Singh
Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide
- NewsAvi Kapoor
Cramer Backs This Mining Giant After $1.6B Bet
- NewsVandana Singh
TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show
- NewsAvi Kapoor
Crude Oil Falls Over 2%; ISM Services PMI Rises In April
- News
Price Over Earnings Overview: TG Therapeutics
- NewsMark Putrino
Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.